TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: myelin phagocytosis capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HLA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Scoring of quantitative image metrics in regions of prostate cancer and benign tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean change in hemoglobin (Hgb) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Validity and Reliability of the Shoulder Surgery Expectations Survey
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long term complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of consent to physician-assisted dying
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Response Rate (by investigator)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate (by ICR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of fluorescent nodes resected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean Percent TBWL at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percent TBWL at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall incidence of device and procedure related adverse events through 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of SCI-210
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of SCI-210
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients having daily dose of 10 mg/day within the 90 days after vericiguat initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Days from index date to first occurrence of 10 mg/day dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients having any Vericiguat up-titration within the 90 days after vericiguat initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5km time trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V̇O2peak test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBD cannulation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mask Leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reintubation by 72 hours post-extubation
Endpoint domain: Adverse events/effects
Primary endpoint: Primary influenza protective effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality indicator adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of residual CBD stone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Performance on emotional working memory task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Foundation Pain Index (FPI) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vineland Adaptive Behavior Scales-Third Edition (VABS-III)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acceptability of prophylactic surgical mesh use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact of incisional hernia risk scores on surgical mesh acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of the number of standard drinks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety symptom change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Affective symptom change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective measure of activity change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: TB recurrence free cure
Endpoint domain: Mortality/survival
Primary endpoint: Antireflux competence of stomal end
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of fetal atrio-ventricular block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Respiratory Syncytial Virus (RSV) Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of uterine adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change of knee and ankle passive range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of strength of knee extensors and ankle dorsiflexors muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of tone of hamstring and gastrocnemius muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Baseline assessment completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: End of treatment assessment completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Remote treatment adherence rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction rating index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant attendance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall number of participants with treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Health related quality of life after cancer treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Disease Specific Quality of Life after cancer treatment in Colorectal - EORTC QLQ-CR29
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Disease Specific Quality of Life after cancer treatment in Breast- EORTC QLQ-BR49
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pure-tone audiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech audiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cathepsin B and Pentraxin 3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change From Baseline EuroQoL-5 Dimension (EQ-5D) Value 6m
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 6m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry Disability Index (ODI) 12m
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Respiratory strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of Candida yeast strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of patients with knee OA, CLBP, and CNP presenting with CS symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of CIPN grade II and higher
Endpoint domain: Adverse events/effects
Primary endpoint: Change in maternal CB-ITM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse drug reactions to 6-mercaptopurine
Endpoint domain: Adverse events/effects
Primary endpoint: ventricular pacing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dynamic cerebral autoregulation parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PPP-serotonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the diastolic function of the right and left ventricles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mean and diastolic pressure of the pulmonary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serological response to the anti-SARS-CoV-2 mRNA vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of AFib Detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity of AFib Detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of adverse events grade 2 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Left Ventricular Global Longitudinal Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urine PK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants with non-progressive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: In vivo kinetics of ingested glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: In vivo kinetics of endogenous glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: In vivo kinetics of lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Word Reading Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collagen Fibers Thickness in Vaginal Wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collagen Fibers Length in Vaginal Wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of the Vaginal Wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected and baseline-corrected sapropterin AUC0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected and baseline-corrected sapropterin AUC0-inf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected and baseline-corrected sapropterin Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in copeptin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause mortality risk ratio
Endpoint domain: Mortality/survival
Primary endpoint: Levels of study medication in blood and urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited Local and Systemic Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Pediatric Evaluation of Disability Inventory (PEDI-CAT)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change in autonomic modulation of heart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nocturnal duration of deep sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Erythrocytes Membrane Integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Erythrocyte Sedimentation Rate (ESR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma Free Hemoglobin (pFHb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Intent to Commit Violence Against Healthcare Workers
Endpoint domain: Adverse events/effects
Primary endpoint: Need for vasopressor due to progression to shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual analogue scale for lower abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Grip Strength Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fine Grip Strength Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jebsen Taylor Hand Function Test (JTEFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early Wound Healing Score-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at Suture Removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ki-67+ Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity and specificity of 3D-Ultrasonography and MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 Contamination Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants with campylobacteriosis patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Oocyte number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: engagement in self-monitoring body weight
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: engagement in self-monitoring steps
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: engagement in self-monitoring dietary intake
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: recommendation of the weight loss program
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Nonspecific Low Back Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-puncture pain / post-treatment pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in PROMIS-29 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Pain Impact Score (PIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Global Impression of Change (PGIC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported STI diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: prevalence of gonadal changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Substrate characterization of the left atrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional characterization of the left atrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nutritional status - Albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inflammatory status - C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the electromyographic recorded values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the perception of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Taxonomic composition of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in performance accuracy in Geneva Emotion Recognition Test (GERT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in performance response times in Geneva Emotion Recognition Test (GERT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in performance reaction times in Social decision-making task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Effective dose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Physiological measurements during cardiopulmonary bypass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-time success rate of body position placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The time required for the nurse to guide it to complete the body position placement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time for nurses to conduct physical position education
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fugl-Meyer Assessment of upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily use of prescription opioids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Coronal Cobb angle change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking and Remembering Test (WART)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Psychiatric symptoms related to opioid misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type of misuse (opioid vs. combined with other substances)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with modified Rankin Score 0-2 at day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total acne lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of regression to normal endometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Clinical change in leukoplakia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histologic change in leukoplakia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of the study device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in treating diabetic peripheral neuralgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: systolic blood pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microbiome composition analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Percent Hepatic Steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Onset of NAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of fear of cancer recurrence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in walking velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent positive agreement between self-collected saliva samples and healthcare-worker collected nasopharyngeal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent negative agreement between self-collected saliva samples and healthcare-worker collected nasopharyngeal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent overall agreement between self-collected saliva samples and healthcare-worker collected nasopharyngeal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance using Berg Balance Scale (BBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental treatment success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPI Performance on Hypotension Prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with unintended initial dissection
Endpoint domain: Adverse events/effects
Primary endpoint: Stent expansion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful IUD self-removal rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observer's Assessment of Alertness/Sedation scale (OAAS/S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibromyalgia Impact Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in left atrial anteroposterior diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in interventricular septum thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in left ventricular posterior wall thickness at end diastole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in left ventricular end diastolic diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in left ventricular end systolic diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient state index level (PSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ventricular arrhythmia numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ICD shock requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Electronic medical record (EMR) portal knowledge assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning